Professor University of Manitoba Winnipeg, Manitoba, E-mail: firstname.lastname@example.org
After the successful completion of the microbiology conference series, we are pleased to welcome you to the "11th International Conference on New Frontiers in Clinical Microbiology and Infectious Diseases." The congress is scheduled to take place on June 26-27, 2020 Paris, France in the beautiful city of Paris, France. This 2020 microbiology Conference will give you exemplary experience and great insights in the field of research.
The global clinical microbiology share value was valued at USD 9.1 billion in 2016 and is supposed to develop at a CAGR of 6.7% over the forecast period. Continuously rising incidence of infectious diseases is the main cause for market growth.
Infectious diseases are majorly diagnosed by using clinical tests. According to the Centres for Disease Control and Prevention (CDC), in 2014, approximately 9,421 new cases of tuberculosis, 51,455 new cases of salmonella and 433 new cases of meningococcal diseases were recognized and in 2017 around 1,688,780 new cases of cancer were diagnosed by the American Cancer Society. Because of increased generality of infections clinical tests are used as primary identification tool and are expected to constant market growth in future.
The expected market share of clinical microbiology is approximately USD 16.7billion by 2025. As the numbers describing the development and importance of the diversified field i.e. Clinical Microbiology.
In recent years, the market for microbiology has seen significant growth directly on the back of the increasing number of procedures for organ transplantation. In addition, an increase in the rate of organ donation and an increase in the prevalence of chronic diseases is expected.
Elena Smith | Program Manager
Contact No: +44-203-769-1778
WhatsApp No: +447588784761